Technical Analysis for CKPT - Checkpoint Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 3.74 1.36% 0.05
CKPT closed up 1.36 percent on Tuesday, April 23, 2019, on 2.34 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CKPT trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
Stochastic Reached Overbought Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%

Older signals for CKPT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology targeted antibodies. The portfolio of antibodies that it licensed includes antibodies targeting programmed death-ligand 1 (PD-L1), glucocorticoid-induced Tumor necrosis factor receptor (TNFR) related protein (GITR) and carbonic anhydrase IX (CAIX). It focuses on developing the immuno-oncology and checkpoint inhibitor antibodies. It is developing three oral, small molecules, targeted anti-cancer agents, consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). Its pipeline of products includes CK-101 and CK-103.
Medicine Immunology Antibodies Chemotherapy Immune System Cancer Immunotherapy Epidermal Growth Factor Receptor Solid Tumor Cancers Immune Checkpoint Checkpoint Inhibitor
Is CKPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.11
52 Week Low 1.5
Average Volume 42,038
200-Day Moving Average 3.0278
50-Day Moving Average 3.1072
20-Day Moving Average 3.0625
10-Day Moving Average 3.151
Average True Range 0.3188
ADX 18.77
+DI 26.4181
-DI 14.4189
Chandelier Exit (Long, 3 ATRs ) 2.7936
Chandelier Exit (Short, 3 ATRs ) 3.5664
Upper Bollinger Band 3.5929
Lower Bollinger Band 2.5321
Percent B (%b) 1.14
BandWidth 34.638367
MACD Line 0.0917
MACD Signal Line 0.0131
MACD Histogram 0.0787
Fundamentals Value
Market Cap 94.88 Million
Num Shares 25.4 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -3.40
Price-to-Sales 75.20
Price-to-Book 6.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.30
Resistance 3 (R3) 4.24 3.99 4.20
Resistance 2 (R2) 3.99 3.85 4.02 4.17
Resistance 1 (R1) 3.87 3.76 3.75 3.93 4.14
Pivot Point 3.62 3.62 3.56 3.65 3.62
Support 1 (S1) 3.50 3.48 3.38 3.56 3.34
Support 2 (S2) 3.25 3.39 3.28 3.31
Support 3 (S3) 3.13 3.25 3.28
Support 4 (S4) 3.19